Pharmacogenomics on Verge of Explosion Acceleratina Technoloaies Creatina the Perfect Storm

摘要

While pharmacogenomics is already influencing the way many ill- nesses are treated, accelerating technology is about to change the game altogether, predicts Randy Scott, co-founder and executive chairman of Genomic Health (Redwood City, Calif.), developer of the Oncotype Dx tests for breast and colon cancer.